Follow
Lidija Beketic-Oreskovic
Lidija Beketic-Oreskovic
Professor of Clinical Oncology, School of Medicine University of Zagreb and UHC Sestre Milosrdnice
Verified email at mef.hr
Title
Cited by
Cited by
Year
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
BI Sikic, GA Fisher, BL Lum, J Halsey, L Beketic-Oreskovic, G Chen
Cancer chemotherapy and pharmacology 40, S13-S19, 1997
3561997
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol)
C Dumontet, GE Duran, KA Steger, L Beketic-Oreskovic, BI Sikic
Cancer research 56 (5), 1091-1097, 1996
1501996
Tumor markers in breast cancer–evaluation of their clinical usefulness
P Marić, P Ozretić, S Levanat, S Orešković, K Antunac, ...
Collegium antropologicum 35 (1), 241-247, 2011
1342011
Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdrl gene activation by the cyclosporin PSC 833
L Beketic-Oreskovic, GE Durán, G Chen, C Dumontet, BI Sikic
JNCI: Journal of the National Cancer Institute 87 (21), 1593-1602, 1995
1101995
A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma
S Oreskovic, D Babic, D Kalafatic, D Barisic, L Beketic-Oreskovic
Gynecologic oncology 93 (1), 34-40, 2004
972004
Conjunctival melanoma-epidemiological trends and features
S Kaštelan, A Gverović Antunica, L Beketić Orešković, J Salopek Rabatić, ...
Pathology & Oncology Research 24, 787-796, 2018
692018
Fertility after breast cancer treatment
M Kasum, L Beketić-Orešković, PF Peddi, S Orešković, RH Johnson
European Journal of Obstetrics & Gynecology and Reproductive Biology 173, 13-18, 2014
662014
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells
GK Chen, GE Durán, A Mangili, L Beketic-Oreskovic, BI Sikic
British journal of cancer 83 (7), 892-898, 2000
552000
Thrombosis following ovarian hyperstimulation syndrome
M Kasum, D Danolić, S Orešković, D Ježek, L Beketić-Orešković, M Pekez
Gynecological endocrinology 30 (11), 764-768, 2014
442014
Fertility preservation in young women with early-stage breast cancer
P Vuković, M Kasum, J Raguž, N Lonjak, S Bilić Knežević, I Orešković, ...
Acta Clinica Croatica 58 (1.), 147-156, 2019
382019
Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients
P Ozretic, I Alvir, B Sarcevic, Z Vujaskovic, Z Rendic-Miocevic, A Roguljic, ...
The International journal of biological markers 33 (1), 109-115, 2018
382018
Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants
P Vuković, FA Peccatori, C Massarotti, MS Miralles, L Beketić-Orešković, ...
Critical Reviews in Oncology/Hematology 157, 103201, 2021
362021
Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in breast cancer patients
L Beketic-Oreskovic, P Ozretic, ZN Rabbani, IL Jackson, B Sarcevic, ...
Pathology & Oncology Research 17, 593-603, 2011
362011
Resistance of human larynx carcinoma cells to cisplatin, γ-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes
M Osmak, L Beketić-Orešković, M Matulić, J Sorić
Mutation Research Letters 303 (3), 113-120, 1993
261993
Kirurška onkologija
M Stanec, DV Vrdoljak, M Turić, L Beketić-Orešković, V Beroš, G Brozović
Zagreb: Medicinska naklada, 294-302, 2011
252011
Immunotherapy for uveal melanoma-current knowledge and perspectives
S Kaštelan, AG Antunica, LB Oresković, G Pelčić, E Kasun, K Hat
Current medicinal chemistry 27 (8), 1350-1366, 2020
242020
Kliničke upute hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke
R Šeparović, M Ban, T Silovska, L Beketić Orešković, Ž Soldić, P Podolski, ...
Liječnički vjesnik 137 (5-6), 0-0, 2015
22*2015
Dopamine agonists in prevention of ovarian hyperstimulation syndrome
M Kasum, H Vrčić, P Stanić, D Ježek, S Orešković, L Beketić-Orešković, ...
Gynecological Endocrinology 30 (12), 845-849, 2014
222014
Fertility preservation with ovarian stimulation protocols prior to cancer treatment
M Kasum, V Šimunić, S Orešković, L Beketić-Orešković
Gynecological endocrinology 30 (3), 182-186, 2014
212014
Assessing the clinical significance of tumor markers in common neoplasms
L Beketic-Oreskovic, P Maric, P Ozretic, D Oreskovic, M Ajdukovic, ...
Front Biosci (Elite Ed) 4 (7), 2558-2578, 2012
202012
The system can't perform the operation now. Try again later.
Articles 1–20